SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Galmed Pharmaceuticals Q1 EPS $(0.290) Beats $(0.370) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.290) per share which beat the analyst consensus estimate of $(0.370) by 21.62 percent. This is a 70.59 percent decrease over losses of $(0.170) per

Benzinga · 05/14/2020 11:04

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.290) per share which beat the analyst consensus estimate of $(0.370) by 21.62 percent. This is a 70.59 percent decrease over losses of $(0.170) per share from the same period last year.